| |
| |
|
| Insider
Information: |
Rubino Richard J |
| Relationship: |
Chief Financial Officer |
| City: |
Franklin Lakes |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
442,830 |
|
|
Indirect Shares
|
8,742 |
|
|
| Direct
Value |
$5,397,539 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
451,572 |
|
|
| Total
Value |
$5,397,539 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medco Health Solutions Inc |
MHS |
SVP, Finance & CFO |
2012-02-27 |
88,893 |
2012-02-27 |
8,742 |
Premium* |
|
|
Aerie Pharmaceuticals Inc |
AERI |
Chief Financial Officer |
2021-02-23 |
353,937 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
70 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial OfficerOfficer |
• – – |
2013-10-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
371,034 |
|
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2013-10-30 |
4 |
B |
$10.00 |
$100,000 |
D/D |
10,000 |
381,034 |
2.74 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2015-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,063 |
390,097 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2016-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
400,097 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2016-02-25 |
5 |
D |
$16.34 |
$15,768 |
D/D |
(965) |
399,132 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,780 |
403,912 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2017-02-24 |
4 |
D |
$44.55 |
$41,521 |
D/D |
(932) |
402,980 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2017-02-25 |
4 |
D |
$44.55 |
$37,645 |
D/D |
(845) |
402,135 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,667 |
412,802 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2018-02-23 |
4 |
D |
$53.85 |
$22,079 |
D/D |
(410) |
419,883 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2018-02-24 |
4 |
D |
$53.85 |
$46,149 |
D/D |
(857) |
419,026 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2018-02-25 |
4 |
D |
$53.85 |
$41,788 |
D/D |
(776) |
418,250 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2018-04-12 |
4 |
D |
$53.40 |
$82,717 |
D/D |
(1,549) |
420,293 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2018-04-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,040 |
421,842 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2018-09-13 |
4 |
S |
$60.17 |
$2,076,608 |
D/D |
(34,512) |
383,738 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2018-09-14 |
4 |
AS |
$60.00 |
$120 |
D/D |
(2) |
383,736 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2018-09-26 |
4 |
AS |
$60.18 |
$3,009,445 |
D/D |
(50,000) |
333,736 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2018-09-27 |
4 |
AS |
$60.36 |
$1,002,386 |
D/D |
(16,605) |
317,131 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2019-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,667 |
327,798 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2019-02-08 |
4 |
D |
$40.39 |
$41,844 |
D/D |
(1,036) |
326,762 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2019-02-23 |
4 |
D |
$40.04 |
$16,416 |
D/D |
(410) |
326,352 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2019-02-24 |
4 |
D |
$40.04 |
$34,314 |
D/D |
(857) |
325,495 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2019-02-25 |
4 |
D |
$40.18 |
$31,220 |
D/D |
(777) |
324,718 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2019-04-12 |
4 |
D |
$41.89 |
$64,888 |
D/D |
(1,549) |
323,169 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2019-05-16 |
4 |
D |
$40.54 |
$94,134 |
D/D |
(2,322) |
334,406 |
0 |
- |
|
70 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
